Use of serialisation can form part of an anti-counterfeiting strategy but adoption of technologies is needed for successful implementation. Pharmaceutical companies can, according to Fairfield, save time, money and effort when implementing serialisation by choosing the right technology.
Fairfield’s scanner is designed to fit into new or existing processes, either on- or off-line. “It can be as simple as a straight swap for existing technology”, said Lee Wragg, business development director at Fairfield, and offers “unmatched code reading performance”.
When installed the system can, in one scan, read 1D barcodes, Pharmacodes and 2D data matrices. Fairfield has experience using 2D barcodes to track surgical instruments and has applied this to its pharmaceutical packaging serialisation scanner.
France, Turkey and California are among the regions adopting 2D barcodes. The system is also backed by the European Federation of Pharmaceutical Industries and Associations (EFPIA) which, in April 2010, said its anti-counterfeiting pilot scheme was a success.
Speaking in April Colin Mackay, an EFPIA spokesperson, told in-PharmaTechnologist 2D barcodes "are considerably cheaper than full track-and-trace such as an RFID based system”. Despite this they are a robust and effective anti-counterfeiting system, said Mackay.
“Fake products can creep in at any part of the chain and this system is an important component of the validation process. It enables clients to read any valid current code, without having to change scanners, saving masses of time and effort”, said Mark Lynch, MD at Fairfield.